MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 3, 2006; DOI: 10.1124/mol.106.027847


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.027847v1
70/5/1555    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamel, E.
Right arrow Articles by Sorensen, E. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamel, E.
Right arrow Articles by Sorensen, E. J


Received for publication June 14, 2006.
Revised July 31, 2006.
Accepted for publication August 1, 2006.

Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly

Ernest Hamel 1*, Billy W Day 2, John H Miller 3, M Katherine Jung 4, Peter T Northcote 3, Arun K Ghosh 5, Dennis P Curran 2, Mark Cushman 5, K C Nicolaou 6, Ian Paterson 7, Erik J Sorensen 8

1 National Cancer Institute 2 University of Pittsburgh 3 Victoria University of Wellington 4 SAIC-Frederick Inc. 5 Purdue University 6 Scripps Research Institute 7 University of Cambridge 8 Princeton University

* Address correspondence to: E-mail: hamele{at}mail.nih.gov

Abstract

Previous studies on the drug content of pelleted tubulin polymers suggest that peloruside A binds in the laulimalide site, which is distinct from the taxoid site. In a tubulin assembly system containing microtubule-associated proteins and GTP, however, peloruside A was significantly less active than laulimalide, inducing assembly in a manner that was most similar to sarcodictyins A and B. Since peloruside A thus far appears to be the only compound that mimics the action of laulimalide, we examined combinations of microtubule-stabilizing agents for synergistic effects on tubulin assembly. We found that peloruside A and laulimalide showed no synergism but that both compounds could act synergistically with a number of taxoid site agents (paclitaxel, epothilones A/B, discodermolide, dictyostatin, eleutherobin, the steroid derivative 17{beta}-acetoxy-2-ethoxy-6-oxo-B-homo-estra-1,3,5(10)-trien-3-ol, and cyclostreptin). None of the taxoid site compounds showed any synergism with each other. From an initial study with peloruside A and cyclostreptin, we conclude that the synergism phenomenon derives, at least in part, from an apparent lowering of the tubulin critical concentration with drug combinations as compared with single drugs. The apparent binding of peloruside A in the laulimalide site led us to attempt construction of a pharmacophore model based on superposition of an energy-minimized structure of peloruside A on the crystal structure of laulimalide. Although the different sizes of the macrocycles limited our ability to superimpose the two molecules, atom correspondences that were observed were consistent with the difficulty so far experienced in creation of fully active analogues of laulimalide.


Key words: Structure-activity relationships and modeling, Structure/function/mechanism, Cytoskeletal targets


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
P. G. Morris and M. N. Fornier
Microtubule Active Agents: Beyond the Taxane Frontier
Clin. Cancer Res., November 15, 2008; 14(22): 7167 - 7172.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics